Amlodipine Placebo

DRUG3 trials

Sponsors

Takeda, Shenzhen Ausa Pharmed Co.,Ltd, Celltrion Pharm, Inc.

Conditions

HypercholesterolemiaHypertensionMTHFR 677 TT Genotype

Phase 3

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

WithdrawnNCT02969265

TakedaHypertension

Start: 2017-05-09End: 2018-07-26Updated: 2017-06-09

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

CompletedNCT07564726

Celltrion Pharm, Inc.Hypercholesterolemia, Hypertension

Start: 2022-08-05End: 2024-02-13Updated: 2026-05-08

Phase 4

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

RecruitingNCT04974151

Shenzhen Ausa Pharmed Co.,LtdHypertension, MTHFR 677 TT Genotype

Start: 2024-08-22End: 2029-06-30Target: 24000Updated: 2025-02-26